Junhua Wu

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 18

Top Venues

Cancer biology & therapy

FEBS open bio

Cancer communications (London, England)

BioMed research international

Nanjing University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Nanjing University Sep 01 2002 - Jul 01 2007

China

PHD :: Life School

Publications

Ding Ma, Shuwen Liu, Kua Liu, Lingkai Kong, Lingjun Xiao, Qilei Xin, Chunping Jiang, Junhua Wu
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway. Cancer biology & therapy 25 (1) (2024)
Lingkai Kong, Qinyu He, Ding Ma, Weiwei Shi, Qilei Xin, Chunping Jiang, Junhua Wu
Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT. FEBS open bio 14 (5) (2024)
Ding Ma, Shuwen Liu, Kua Liu, Lingkai Kong, Lingjun Xiao, Qilei Xin, Chunping Jiang, Junhua Wu
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway. Cancer biology & therapy 25 (1) (2024)
Lingjun Xiao, Louqian Zhang, Ciliang Guo, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu
"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity. Cancer communications (London, England) (2024)
Lingjun Xiao, Louqian Zhang, Ciliang Guo, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu
"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity. Cancer communications (London, England) 44 (7) (2024)
Lingjun Xiao, Louqian Zhang, Ciliang Guo, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu
"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity. Cancer communications (London, England) 44 (7) (2024)
Lingjun Xiao, Louqian Zhang, Ciliang Guo, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu
"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity. Cancer communications (London, England) 44 (7) (2024)
Ding Ma, Shuwen Liu, Kua Liu, Lingkai Kong, Lingjun Xiao, Qilei Xin, Chunping Jiang, Junhua Wu
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway. Cancer biology & therapy 25 (1) (2024)
Lingkai Kong, Qinyu He, Ding Ma, Weiwei Shi, Qilei Xin, Chunping Jiang, Junhua Wu
Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT. FEBS open bio 14 (5) (2024)
Lingkai Kong, Qinyu He, Ding Ma, Weiwei Shi, Qilei Xin, Chunping Jiang, Junhua Wu
Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT. FEBS open bio (2024)
Ding Ma, Shuwen Liu, Kua Liu, Lingkai Kong, Lingjun Xiao, Qilei Xin, Chunping Jiang, Junhua Wu
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway. Cancer biology & therapy 25 (1) (2024)
Ding Ma, Shuwen Liu, Kua Liu, Lingkai Kong, Lingjun Xiao, Qilei Xin, Chunping Jiang, Junhua Wu
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway. Cancer biology & therapy 25 (1) (2024)
Lingkai Kong, Qinyu He, Ding Ma, Weiwei Shi, Qilei Xin, Chunping Jiang, Junhua Wu
Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT. FEBS open bio 14 (5) (2024)
Lingkai Kong, Qinyu He, Ding Ma, Weiwei Shi, Qilei Xin, Chunping Jiang, Junhua Wu
Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT. FEBS open bio 14 (5) (2024)
Ding Ma, Shuwen Liu, Kua Liu, Lingkai Kong, Lingjun Xiao, Qilei Xin, Chunping Jiang, Junhua Wu
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway. Cancer biology & therapy 25 (1) (2024)
Ciliang Guo, Lingkai Kong, Lingjun Xiao, Kua Liu, Huawei Cui, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies. Cell & bioscience 13 (1) (2023)
Junyi Wu, Xiangjie Xu, Shasha Wu, Weiwei Shi, Guang Zhang, Yin Cao, Zhongxia Wang, Junhua Wu, Chunping Jiang
UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma. Cancer medicine (2023)
Ding Ma, Shuwen Liu, Lili Hu, Qinyu He, Weiwei Shi, Dongliang Yan, Yin Cao, Guang Zhang, Zhongxia Wang, Junhua Wu, Chunping Jiang
Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity. Journal of cellular and molecular medicine 25 (14) (2021)
Zhongxia Wang, Chunping Jiang, Wei-Bo Chen, Guang Zhang, Dongjun Luo, Yin Cao, Junhua Wu, Yitao Ding, Baorui Liu
Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells. BioMed research international 2014 (2014)
Dongjun Luo, Zhongxia Wang, Junyi Wu, Chunping Jiang, Junhua Wu
The role of hypoxia inducible factor-1 in hepatocellular carcinoma. BioMed research international 2014 (2014)

Junhua Wu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Junhua Wu